Intellegens and CPI awarded £1.6m Innovate UK grant to advance manufacture of oligonucleotide therapeutics with machine learning
Cambridge, UK - Intellegens, a company applying machine learning (ML) to accelerate innovation in R&D, announces that it has secured a £1.6m grant from Innovate UK, part of UK Research and Innovation (UKRI), to apply ML in the emerging field of oligonucleotide therapies.
Intellegens selected as AI company of the year
Intellegens has won the ‘AI Company of the Year’ award at the Cambridge Independent Science and Technology Awards, selected by an expert panel from a strong shortlist of technology businesses following a record number of entries.
Intellegens to lead consortium focused on ‘trustworthy AI’ for UK materials and chemicals R & D
Project to help drive adoption of machine learning wins funding from Innovate UK.
New academic programme lowers cost for university researchers to access leading-edge machine learning method
Academics in chemistry, materials research and life sciences can tap into advanced AI tool
Intellegens announces the Alchemite™ 2022 Autumn Release, focused on accelerating innovation in practice
CAMBRIDGE, UK – Intellegens announces the 2022 Autumn Release of its Alchemite™ machine learning software, focused on key practical tasks to accelerate innovation for chemicals, materials, and manufacturing.
Knowledge from noise - new algorithm turns uncertainty into a positive for industrial R&D and beyond
A recently published paper in the prestigious journal Applied Intelligence introduces a novel method by which machine learning can extract valuable information from uncertainty or noise in input data.
NASA validation boosts Intellegens
A new paper from the NASA Glenn Research Center applies the Alchemite™ machine learning software from Cambridge-based Intellegens to the design of shape memory alloys and heat exchangers. The study validates the application of the technology in the design and development of new materials and components, providing further evidence of its value for industrial R&D.
Intellegens shares new industrial applications for its machine learning technology
Cambridge-based machine learning specialist Intellegens has published details of more collaborations with leading R&D organisations in materials, chemicals, and manufacturing sectors. These include projects with NASA, Lucideon, Johnson Matthey, and International Flavors and Fragrances (IFF).
Intellegens wins two international awards and launches machine learning package for Additive Manufacturing
Cambridge-based artificial intelligence (AI) software specialist Intellegens scooped a double award win at the recent Additive Manufacturing (AM) Innovation Awards, organised by the American Society of Mechanical Engineers (ASME). The business won both the Best-in-Class Software and Startup Innovation Awards, in competition with an international field of 40 other technology providers.
Intellegens wins AM Tech Forum Awards
The Intellegens Additive Manufacturing solution was a winner in the Innovation Awards at last night’s AM Tech Forum events, organised by the American Society of Mechanical Engineers.
Intellegens and Ansys to empower additive manufacturing with material intelligence through machine learning
Machine learning specialist Intellegens and engineering simulation leader Ansys have announced a collaboration to integrate machine learning methods into Additive Manufacturing (AM) workflows, accelerating the development of reliable and repeatable AM processes.
Machine learning makes light work of additive manufacturing aerospace alloys
Machine learning technology will be used to make the additive manufacturing (AM) process of metallic alloys for aerospace cheaper and faster, encouraging the production of lightweight, energy-efficient aircraft to support net-zero targets for aviation.
Innovate UK funded project produces next-generation AI drug discovery platform
CAMBRIDGE, and MACCLESFIELD, UK, 3 December 2020 – The consortium behind the DeepADMET project set up to advance artificial intelligence (AI) technologies for drug discovery, today announced the successful conclusion of this project which was funded by Innovate UK, the UK’s innovation agency.
Intellegens awarded Innovate UK funding to model COVID-19 data and improve pandemic management
Intellegens has received funding from Innovate UK to model COVID-19 data and improve the management of future coronavirus outbreaks and other infectious diseases. The tool, which will be based on Intellegens' unique deep-learning algorithm Alchemite™, will help understand how policy changes might impact outcomes, helping inform decision-making.
Optibrium and Intellegens achieve further success in Open Source Malaria initiative
Optibrium™, leading providers of software and services for drug discovery, and Intellegens™, a spin-out from the University of Cambridge with a unique Artificial Intelligence (AI) toolset, today announced they have reached a further significant milestone in their contribution to the Open Source Malaria (OSM) initiative.
Data-driven machine learning is the best approach for advanced battery modelling
A collaboration between the University of Cambridge, A*STAR and Nanyang Technological University in Singapore, assessed methods for predicting EV battery states and revealed that a data-driven machine learning model offers the most accurate predictions for state of charge and health.
Intellegens is one of 10 startups selected for ATI Boeing Accelerator to boost UK innovation in aerospace
Intellegens, a Cambridge tech start-up with a unique Artificial Intelligence toolset that can train deep neural networks from sparse or noisy data, has been selected to be part of the ATI Boeing Accelerator programme.
ANSYS Granta, Intellegens and University of Birmingham secure funding to improve battery metrics with artificial intelligence
A collaboration between ANSYS Granta, Cambridge AI start-up Intellegens, and the University of Birmingham has secured funding from the Faraday Battery Challenge to optimise the battery manufacturing processes helping ensure the UK leads the world in the transition to a low carbon economy.
Intellegens and Optibrium celebrate success in global challenge to find novel antimalarial compounds
Intellegens, an artificial intelligence (AI) start-up, and, Optibrium™, leading providers of software and services for drug discovery, have announced joint success in the Open Source Malaria (OSM) global initiative aimed at identifying the best predictive models for antimalarial compounds.
Intellegens to discuss AI at The Advanced Materials Show 2019
Machine learning and artificial intelligence (AI) are transforming all aspects of daily life, but how can we use this powerful technology to search for new materials that will transform industries? The answer to this question will be addressed this week at The Advanced Materials Show 2019 by Dr Gareth Conduit, Chief Technology Officer at Intellegens - the Cambridge-based company with a unique…
Novel deep learning drug discovery platform gets £1 million innovation boost
Funding to support Artificial Intelligence (AI) in drug discovery takes a significant step forward today as Optibrium, Intellegens, and Medicines Discovery Catapult secure a grant from Innovate UK to fund a £1 million project.
Intellegens delivers speaker paper on using AI to design advanced materials
Using artificial intelligence (AI) and harnessing the power of deep learning to guide the design of new advanced materials, is the topic of a speaker paper that will be delivered at Engineering Materials Live later this week in Duxford.
Intellegens secures first commercial contract for Alchemite™ technology
The potential of Intellegens’ Alchemite™ artificial intelligence (AI) technology has been demonstrated with a collaboration between the Cambridge-based company and e-Therapeutics; the Oxford-based pioneer of Network-Driven Drug Discovery (NDD).
New Cambridge spin-out, Intellegens, secures funding to develop its innovative approach to AI
Intellegens, a new company spun out of the University of Cambridge to develop and commercialise novel artificial intelligence (AI) software, has received funding to help further develop its toolset.